Advertisement
Advertisement
Wuxi Biologics
TOPIC
 / company

Wuxi Biologics

Wuxi Biologics
Wuxi Biologics
Wuxi Biologics is a pharmaceutical research and services company based in Wuxi, Jiangsu province. It counts 16 of the world's top 20 drug makers as customers and 28 of China's 50 largest medicine producers. The company supplied ingredients for AstraZeneca's Covid-19 vaccine. It is one of six businesses founded by its chairman Ge Li, along with Wuxi Apptec.
Chairman / President
Li Ge
CEO / Managing Director
Chen Zhisheng
CFO / Finance Director
Tu Ming
Industry
Biopharmaceutical
Website
wuxibiologics.com.cn
Headquarters address
No. 108 Mashan Meiliang Road, Binhu Distroct, Wuxi City, Jiangsu Province, China
Stock Code
SEHK:2269
Year founded
2010
LATEST China Science NEWS

Unlimited petrol? Chinese firm claims it can produce fuel from air and water

videocam
6
Employees inspect equipment at a petrochemical refinery in northeast China’s Heilongjiang province. China is exploring alternatives to fossil fuels as part of an effort to reduce its reliance on imported crude oil. Photo: VCG

A rare earth ‘China solution’ that leaves US defence agency in the cold

videocam
A mini-fridge built with the alloy has achieved temperatures extremely close to absolute zero using no moving parts. Photo: Shutterstock

China and Chile wrap up Atacama Trench mission as US pressure mounts

videocam
Scientists (from left) Du Mengran, Deng Yuqing and Osvaldo Ulloa in the manned submersible at Atacama Trench. Photo: Handout

How China gets more bang for its military buck than the US

videocam
5
Illustration: Davies Christian

Could this Chinese breakthrough pave way for global organ transplant system?

videocam
With preservation limited to a single day at most, transplants remain more like emergency procedures than elective surgeries. Photo: Shutterstock
MORE China Science NEWS
Despite the headwinds, there is growing interest from multinational pharmaceutical companies in partnering with Chinese biotech firms. Photo: Getty Images
China’s private sector

US reshoring drive casts shadow over China’s contract drug makers, analyst says

Strong order backlogs underpin earnings through 2027, but analysts warn longer-term demand is less certain as US firms reshore production.

Hong Kong stock market

WuXi Biologics earnings jump as ‘follow and win the molecule’ strategy pays off

Hong Kong stock market

Hong Kong stocks rise as positive holiday bias sets in ahead of Lunar New Year

Banking & finance

Global funds, from BlackRock to Temasek, back China’s largest biotech firms

Global institutional investors have built up sizeable positions in firms including Innovent, 3SBio, WuXi Biologics, Jiangsu Hengrui, Akeso and BeOne.

Global investors have reaped sizeable rewards from their investments in Hong Kong-listed biotech and pharmaceutical companies in the past year. Photo: Shutterstock
Hong Kong stock market

Hong Kong stocks climb as yuan strengthens and investors broaden focus beyond US

Hang Seng Index advances as investors shift focus, boosting Asian equities, with pharmaceutical and healthcare shares leading gainers.

United States

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

Advertisement
Advertisement
Advertisement
Science

Why US lawmakers killed a proposal targeting science efforts with China

US researchers and industry experts warn that even the revised version may have unintended consequences.

videocam
11
A US defence bill, now awaiting President Donald Trump’s signature, includes new restrictions aimed at the medical industry and supply chains, blocking federal funds from going to biotechnology companies linked to so-called adversaries. Photo: Reuters
China manufacturing

China’s biotech firms may see ‘major breakthroughs’ within a decade. Here’s why

Strong manufacturing base a driving force behind overseas expansion, but industry leaders and analysts say hurdles remain.

videocam
Shanghai

China bets on bio-manufacturing as new growth engine, bid for tech self-reliance

The pilot-scale platforms are aimed at helping innovators overcome hurdles in R&D and manufacturing before achieving commercial production.

Hong Kong stock market

Ignore China’s innovation boom ‘at your own peril’, General Atlantic CEO warns

Easing of US-China tensions and strong Hong Kong equity market present new opportunities, William Ford says at the Family Business Summit.

General Atlantic chairman and CEO William Ford at the Rosewood Hotel in Hong Kong on November 6. Photo: Jonathan Wong
Hong Kong stock market

Hong Kong stocks post longest decline in 9 months on renewed US-China tensions

Markets react to Trump’s threat to impose a 100 per cent tariff on all Chinese imports and restrict critical software exports from November.

The Hang Seng Index is headed for its steepest decline since a 13 per cent plunge on April 7. Photo: Jelly Tse
Biomedicine: Geopolitics

Trump’s tariffs on imported drugs ‘not a big concern’ for China’s pharma firms

Chinese drug makers have ‘minimal sales exposure to the US’, Jefferies analysts say.

Hong Kong stock market

Hong Kong stocks cap weekly decline on valuation, tariff jitters

‘Gravity has reasserted itself’ and the global US$15 trillion rebound this year ‘now feels stretched’, investor says.

Hong Kong stock market

Chinese biotechs get a shot in the arm from policy support, licensing deals

‘We are on an upcycle in the industry and sentiment is very strong,’ Xufunds Investment fund manager Wang Chen says.

Shares of WuXi Biologics have more than doubled year to date. Photo: Shutterstock
Biomedicine: Companies

Chinese biotech firm MGI’s DNA sequencers gaining in the market, BGI CEO says

MGI’s latest product, the DNBSEQ-T7+, can sequence 144 human genomes a day, or one every 10 minutes.

MGI Tech’s DNA sequencers offer the best “comprehensive value” in terms of time, quality and cost, according to BGI Group CEO Yin Ye. Photo: Shutterstock
Hong Kong stock market

Hong Kong stocks slip from 4-year high amid fears of US sanctions on drug makers

The Trump administration has been discussing severe restrictions on medicines from China, according to The New York Times.

Hong Kong stock market

Alibaba surge leads Hong Kong stocks to biggest gain in 2 weeks

Hong Kong stocks are undervalued, and a ‘liquidity friendly environment’ is set to propel them higher, analyst says.

Advertisement
Advertisement
Advertisement
Hong Kong stock market

Hong Kong stocks rebound on US-China trade talk optimism

Hang Seng Index recovers from an intraday loss of as much as 0.9 per cent, snapping a four-day losing streak.

People walk past an electronic board showing the Hang Seng Index in Hong Kong. Photo: Zuma Press Wire/dpa
Hong Kong stock market

Hong Kong stocks sustain 3-year-high level on trade optimism

A US deal with Japan and scheduled talks with China reduce concerns about damage to the global economy from trade conflicts.

Hong Kong stock market

Hong Kong stocks cap weekly gain on earnings optimism

Wuxi AppTec jumps after it says its first-half profit likely more than doubled from a year earlier.

Hong Kong stock market

Hong Kong stocks gyrate amid Iran conflict after US strike, Hormuz threat

Oil futures surge after US President Donald Trump says attacks ‘obliterated’ targets and Iran threatens to close key oil shipping route.

Oil tankers pass through the Strait of Hormuz in a 2018 file photo. Photo: Reuters
Hong Kong stock market

Hong Kong stocks rise on China policy hopes after soft economic data

China’s industrial output and fixed-asset investment fell short in May, and the downturn in the property market deepened.

Workers pack knives at a factory in Yangjiang, south China’s Guangdong province, on June 11, 2025. Photo: Xinhua
Hong Kong stock market

Hong Kong stocks erase gains amid ongoing US-China trade talks

Investors appear to look more cautiously at ongoing US-China trade talks in London.

Hong Kong stock market

Hong Kong stocks jump as US blocks Trump’s tariffs in win for global trade

Hang Seng Index approached a two-month high on bets global trade relations and market sentiment will improve.

videocam
Hong Kong stock market

Hong Kong stocks gain on earnings boost as Meituan beats market consensus

Gains limited by losses in leading carmakers amid lingering concerns about a prolonged price war.

videocam
Exchange Square in Central. Hong Kong. Photo: Sam Tsang
Biomedicine: Companies

Big Chinese pharma can beat Trump’s policies with cost efficiencies: analysts

Trump seeks to slash domestic drug prices, bring back pharmaceutical manufacturing to the US and slap tariffs on imports.

videocam
A humanoid robot is shown delivering drugs at a mock pharmacy in Beijing in April 2025. Photo: EPA-EFE
China Future Tech briefing

Biomedicine | China’s biomedical sector braces for headwinds

The coast isn’t entirely clear for the world’s second-largest biomedical sector, which faces possible tariff increases and US import curbs.

Biomedicine: Companies

China’s WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom

US passed Biosecure Act which would ban federal contracts with targeted firms and their business partners. Legislation explicitly names WuXi.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement